MCL1 and breast carcinoma: In agreement with recent studies, we found that targeting MCL-1 in TN breast cancer cells; in our case using three different BH3-mimetics specific for MCL-1 (UMI-77, S63845 and A1210477); inhibited TN breast cancer cell line growth in vitro.